2023
DOI: 10.1097/mpg.0000000000003860
|View full text |Cite
|
Sign up to set email alerts
|

Budd-Chiari Syndrome—A Single Center Experience From the United Kingdom

Abstract: Pediatric Budd-Chiari syndrome (BCS) is a rare cause of portal hypertension and liver disease in Europe and North America. In order to understand the long-term effect of radiological intervention on BCS we performed a single center retrospective review. Fourteen cases were identified; 6 of 14 (43%) had a congenital thrombophilia with many having multiple prothrombotic mutations. Two were managed with medical anticoagulation alone and two required super-urgent transplant for acute liver failure. The remaining 1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…The indications for TIPS placement have been expanded and refined in recent years. Preemptive TIPS is now the new standard in many centres, and indications are broadened to include non-cirrhotic portal hypertension, portal vein thrombosis, Budd–Chiari syndrome, hepatorenal and hepatopulmonal syndrome, and cases of hepatocellular carcinoma with portosystemic symptoms [ 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 ]. Although technical advancements have decreased post-TIPS morbidity significantly, hepatic encephalopathy (HE) remains a well-known and debilitating complication of TIPS placement (HE) even when present as minimal or grade I HE (‘covert HE’) [ 10 , 11 , 12 , 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…The indications for TIPS placement have been expanded and refined in recent years. Preemptive TIPS is now the new standard in many centres, and indications are broadened to include non-cirrhotic portal hypertension, portal vein thrombosis, Budd–Chiari syndrome, hepatorenal and hepatopulmonal syndrome, and cases of hepatocellular carcinoma with portosystemic symptoms [ 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 ]. Although technical advancements have decreased post-TIPS morbidity significantly, hepatic encephalopathy (HE) remains a well-known and debilitating complication of TIPS placement (HE) even when present as minimal or grade I HE (‘covert HE’) [ 10 , 11 , 12 , 13 ].…”
Section: Introductionmentioning
confidence: 99%